Switching Between Antifibrotics May Help IPF Patients Live Longer

Switching Between Antifibrotics May Help IPF Patients Live Longer

300780

Switching Between Antifibrotics May Help IPF Patients Live Longer

Switching antifibrotic treatment is generally well-tolerated among people with idiopathic pulmonary fibroisis (IPF), and those who did generally lived several years longer than those who did not, a study from Japan reports. Findings suggest that switching from one antifibrotic to another “is feasible and may improve prognosis [disease course] in patients with IPF,” its researchers wrote. The study, “Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study,” was published in the…

You must be logged in to read/download the full post.